Avanos Medical: Q1 Earnings Insights

Shares of Avanos Medical AVNS were unchanged in pre-market trading after the company reported Q1 results.

Quarterly Results

Earnings per share rose 6.67% over the past year to $0.16, which were in line with the estimate of $0.16.

Revenue of $180,400,000 rose by 9.87% year over year, which beat the estimate of $175,220,000.

Outlook

Avanos Medical hasn't issued any earnings guidance for the time being.

Avanos Medical hasn't issued any revenue guidance for the time being.

Conference Call Details

Date: May 06, 2020

Webcast URL: https://www.webcaster4.com/Webcast/Page/939/34129

Technicals

Company's 52-week high was at $48.07

52-week low: $19.46

Price action over last quarter: down 8.19%

Company Profile

Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. The firm operates in one segment, medical devices, which primarily sells products related to pain management, IV Therapy, and respiratory and digestive health. The company divides its Medical Devices segment into two franchises: Pain Management and Chronic Care. Pain Management provides non-opioid products for acute and interventional pain, including cold and compression therapy. Chronic Care aims at addressing digestive and respiratory issues with feeding tubes and catheters. Avanos generates most of its revenue from its Chronic Care franchise and in North America.